Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
ADAPT-PD trial methods and preliminary data published in npj Parkinson’s disease
New MRI labeling extends active scan time for Medtronic DBS systems
First ever FDA approval provides more options to meet patients’ personalized needs, including those with Parkinson’s disease
Deal expands Pain Interventions portfolio, now offering both unipedicular and bipedicular vertebral augmentation solutions
Doubled probe count enables multi-level spine tumor ablations for increased flexibility and efficiency Medtronic plc, a global leader in healthcare technology, today announced that it has received...
86% of subjects preferred closed-loop SCS in a multicenter, randomized, crossover, single blind study of Medtronic’s investigational closed-loop SCS system at one month
24-month European RCT data demonstrates long-term superiority of DTM™ SCS compared with conventional medical management (CMM) for indicated chronic back pain patients not eligible for spine surgery
NOVA Study: On-label, prospective, multicenter, randomized controlled trial compared DTM™ SCS to conventional spinal cord stimulation
Prospective study will evaluate the long-term performance of the closed-loop algorithm and overall patient experience with Medtronic’s next generation, rechargeable spinal cord stimulation device